Ru II -02 exhibited greater antioxidant capacity and inhibited proteasomal activity more potently than Ru II -01 , Ru II -03 , or free curcumin, triggering apoptosis
10.1111/obr.12843 Summary Keywords Chinese botanical drugs, chronic kidney disease, gut-kidney axis, mitochondrial dysfunction, mitochondrial quality control Citation Liu H, Huang S, Chen S, Liang S, Huang M, Li S, Xu Y and Xie B (2026) Pharmacological potential of Chinese botanical drugs in managing chronic kidney disease by targeting mitochondrial quality control
FDA Disclosure: The statements on this website and the products sold herein have not been evaluated by the U.S
& Reisman, D
Mechanism in Stress & Pain Models Beyond sleep regulation, DSIP is heavily researched for its potential as an analgesic and stress-protective agent
Data Usage: You consent to our Privacy Policy